Информация об этой странице недоступна. ·

NCCN develops evidence-based cancer care recommendations used by health care providers worldwide. These frequently updated recommendations are the NCCN Clinical.

Individualized Multidisciplinary CLL Care: Practical Application of Guidelines and Emerging Data · Applying NCCN Guidelines for the Treatment of CLL/SLL in ...

10 июн. 2022 г. · NCCN Recommendations Enrollment in an appropriate clinical trial is recommended for patients with untreated del(17p) CLL.

Expert cancer information presented in plain language with visuals, charts, and definitions to empower patients and caregivers.

The NCCN Guidelines for CLL/SLL underscore the need for a comprehensive evaluation of multiple factors to determine the most appropriate treatment approach for ...

Guidelines for Patients · Chronic Lymphocytic Leukemia-English Version 2024 · Chronic Lymphocytic Leukemia-Arabic Version 2021 ...

NCCN Guidelines® recommend acalabrutinib (CALQUENCE®) as a Category 1, preferred treatment option for CLL.

These NCCN Guidelines Insights discuss the updates to the NCCN Guidelines for CLL/SLL specific to the use of chemotherapy-free treatment options for patients ...

NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) are posted with the latest update date and version number. Guidelines for Patients · Recently Updated Guidelines · Uterine Neoplasms